About U.S. Physical Therapy, Inc.
https://www.usph.comU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
CEO
Christopher J. Reading
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-06-29 | Forward | 3:2 |
| 2001-01-08 | Forward | 2:1 |
ETFs Holding This Stock
IJR.AX
Weight:0.08%
Shares:904.67K
XSMH.TO
Weight:0.08%
Shares:904.67K
VTS.AX
Weight:0.00%
Shares:477.39K
Summary
Showing Top 3 of 144
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:2.29M
Value:$202.27M
BLACKROCK, INC.
Shares:2.18M
Value:$192.09M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Shares:1.35M
Value:$119.38M
Summary
Showing Top 3 of 314
About U.S. Physical Therapy, Inc.
https://www.usph.comU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $164.02M ▼ | $11.54M ▼ | $7.24M ▼ | 4.42% ▼ | $0.48 ▼ | $31.11M ▼ |
| Q2-2025 | $164.18M ▲ | $16.69M ▲ | $8.81M ▼ | 5.37% ▼ | $0.58 ▼ | $31.13M ▲ |
| Q1-2025 | $152.55M ▼ | $11.42M ▼ | $9.9M ▲ | 6.49% ▲ | $0.8 ▲ | $25.47M ▼ |
| Q4-2024 | $180.45M ▲ | $19.16M ▲ | $7.44M ▲ | 4.12% ▲ | $0.52 ▲ | $26.06M ▲ |
| Q3-2024 | $168.03M | $14.38M | $5.53M | 3.29% | $0.39 | $18.74M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $31.1M ▼ | $1.2B ▲ | $413.83M ▼ | $503.57M ▲ |
| Q2-2025 | $34.09M ▼ | $1.18B ▼ | $414.01M ▼ | $500.75M ▲ |
| Q1-2025 | $39.18M ▼ | $1.18B ▲ | $420.68M ▲ | $497.26M ▲ |
| Q4-2024 | $41.36M ▼ | $1.17B ▲ | $408.42M ▲ | $488.93M ▲ |
| Q3-2024 | $116.96M | $1.03B | $358.47M | $482.76M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $17.64M ▼ | $19.94M ▼ | $-11.94M ▲ | $-10.99M ▲ | $-2.98M ▲ | $15.63M ▼ |
| Q2-2025 | $17.72M ▲ | $34.86M ▲ | $-12.71M ▼ | $-27.25M ▼ | $-5.1M ▼ | $31.61M ▲ |
| Q1-2025 | $9.9M ▼ | $-4.67M ▼ | $-6.63M ▲ | $9.12M ▲ | $-2.18M ▲ | $-7.25M ▼ |
| Q4-2024 | $12.49M ▲ | $19.41M ▼ | $-94.85M ▼ | $-153K ▲ | $-75.6M ▼ | $16.92M ▼ |
| Q3-2024 | $9.78M | $22.12M | $-5.84M | $-12.23M | $4.05M | $19.6M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Net Patient Revenues | $150.00M ▲ | $150.00M ▲ | $160.00M ▲ | $160.00M ▲ |
 Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
CEO
Christopher J. Reading
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-06-29 | Forward | 3:2 |
| 2001-01-08 | Forward | 2:1 |
ETFs Holding This Stock
IJR.AX
Weight:0.08%
Shares:904.67K
XSMH.TO
Weight:0.08%
Shares:904.67K
VTS.AX
Weight:0.00%
Shares:477.39K
Summary
Showing Top 3 of 144
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:2.29M
Value:$202.27M
BLACKROCK, INC.
Shares:2.18M
Value:$192.09M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Shares:1.35M
Value:$119.38M
Summary
Showing Top 3 of 314